"Bringing pharmaceutical supply chains back to the USA"


  • 1,079 facilities worldwide that produce the 370 drugs on the World Health Organizationā€˜s (WHO) Essential Medicines List that are marketed in the US. However, just 21 percent of those facilities are based in the US. - FDA

  • Older people and people with pre-existing medical conditions (such as diabetes, heart disease and asthma) appear to be more vulnerable to becoming severely ill with the COVID-19 virus (IDF, Aug'20)

  • Amongst intensive care patients with COVID-19, 32% had diabetes ( US News, Mar'20)



  • For hospitalized COVID-19 patients not in the ICU, 24% had diabetes ( US News, Mar'20)

  • 7% COVID fatality rate amongst those with diabetes instead of average rate of 2%



  • A report from Italy found among 481 patients who died of the COVID, about one-third had diabetes

  • US, 9 out of 10 prescriptions filled are for generic drugs, most of which are manufactured in China and India - FDA, 2019

  • Drug quality inspections outside US has been suspended due to COVID and are considered on a case-by-case basis - FDA, Mar'20



Meet the Team

Cameron Owen

Founder, ex-CEO Aevus Diagnostics
MS, Healthcare Management
Johns Hopkins University
BS, Microbiology - University of Arizona



Pratik Pradhan

MS, Healthcare Management
Johns Hopkins University
B.Tech, Biomedical Engineering - VIT,Vellore




Dr. Debanjan Dhar

Assistant Professor,
Department of Medicine,
Division of Gastroenterology
University of California - San Diego



Contact Us